12 Health Care Stocks Moving In Monday's Intraday Session
Portfolio Pulse from Benzinga Insights
Health care stocks experienced significant movements in Monday's intraday session. Renalytix saw a dramatic increase of 490.4%, while AN2 Therapeutics faced a sharp decline of 75%. Other notable movers include Regencell Bioscience and Genenta Science with substantial gains, and InVivo Therapeutics and TC BioPharm with significant losses.
February 12, 2024 | 5:31 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Genenta Science shares increased by 31.84% to $4.14, with a market cap of $75.4 million.
Genenta Science's notable gain could attract investor interest, potentially leading to a short-term positive impact on its stock.
CONFIDENCE 85
IMPORTANCE 80
RELEVANCE 90
POSITIVE IMPACT
Regencell Bioscience stock rose 39.91% to $10.39, with a market cap of $135.2 million.
The substantial gain in Regencell Bioscience's stock could generate positive investor sentiment, likely leading to a short-term positive impact on its stock.
CONFIDENCE 85
IMPORTANCE 80
RELEVANCE 90
POSITIVE IMPACT
Renalytix stock rose dramatically by 490.4% to $2.25, with a market cap of $112.4 million.
The significant rise in Renalytix's stock price could attract more investors, potentially leading to a short-term positive impact on its stock.
CONFIDENCE 90
IMPORTANCE 90
RELEVANCE 100
NEGATIVE IMPACT
AN2 Therapeutics stock decreased by 75% to $5.01, with a market cap of $149.0 million.
The sharp decline in AN2 Therapeutics' stock price could lead to negative sentiment among investors, likely resulting in a short-term negative impact on its stock.
CONFIDENCE 90
IMPORTANCE 90
RELEVANCE 100